Last 65.15 INR
Change Today -4.30 / -6.19%
Volume 21.6K
BLP On Other Exchanges
Symbol
Exchange
Natl India
As of 5:02 AM 09/16/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for bal pharma ltd (BLP)

Year over year, Bal Pharma Limited has been able to grow their bottom line from 42.8M INR to 50.7M INR primarily through revenue growth (1.5B INR to 1.8B INR). For while the costs associated with cost of goods, SGA and income tax all increased as a percentage of sales, the growth in top line revenues contributed enough to still see net income improve.
View Income Statement In U.S. Dollar
Currency in
Millions of Indian Rupees
As of:Mar 31
2011
INR
Mar 31
2012
Restated
INR
Mar 31
2013
Restated
INR
Mar 31
2014
INR
4 Year
Trend
Revenues1,142.91,396.91,479.11,788.7
TOTAL REVENUES1,142.91,396.91,479.11,788.7
Cost of Goods Sold685.2845.4852.81,050.4
GROSS PROFIT457.7551.5626.4738.3
Selling General & Admin Expenses, Total352.6370.9422.0512.6
R&D Expenses--6.77.99.2
Depreciation & Amortization, Total34.741.348.147.2
Other Operating Expenses-1.720.720.523.0
OTHER OPERATING EXPENSES, TOTAL385.6439.6498.5592.1
OPERATING INCOME72.1111.9127.9146.2
Interest Expense-58.0-62.2-66.8-59.4
Interest and Investment Income0.92.01.91.6
NET INTEREST EXPENSE-57.1-60.3-64.9-57.8
Currency Exchange Gains (Loss)4.4-3.04.54.8
Other Non-Operating Income (Expenses)-9.0-13.8-16.6-27.0
EBT, EXCLUDING UNUSUAL ITEMS10.334.950.966.3
Gain (Loss) on Sale of Assets--8.80.0--
EBT, INCLUDING UNUSUAL ITEMS10.343.750.966.3
Income Tax Expense6.36.18.115.5
Earnings from Continuing Operations4.137.642.850.7
NET INCOME4.137.642.850.7
NET INCOME TO COMMON INCLUDING EXTRA ITEMS4.137.642.850.7
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS4.137.642.850.7
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BLP:IN 65.15 INR -4.30

BLP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for BLP.
View Industry Companies
 

Industry Analysis

BLP

Industry Average

Valuation BLP Industry Range
Price/Earnings 15.5x
Price/Sales 0.5x
Price/Book 1.5x
Price/Cash Flow 9.4x
TEV/Sales 0.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BAL PHARMA LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.